Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics
The utilized 3D printhead employs an innovative hot-melt extrusion (HME) design approach being fed by drug-loaded polymer granules and making filament strands obsolete. Oscillatory rheology is a key tool for understanding the behavior of a polymer melt in extrusion processes. In this study, small am...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/11/2488 |
_version_ | 1797464259496509440 |
---|---|
author | Thomas Pflieger Rakesh Venkatesh Markus Dachtler Karin Eggenreich Stefan Laufer Dominique Lunter |
author_facet | Thomas Pflieger Rakesh Venkatesh Markus Dachtler Karin Eggenreich Stefan Laufer Dominique Lunter |
author_sort | Thomas Pflieger |
collection | DOAJ |
description | The utilized 3D printhead employs an innovative hot-melt extrusion (HME) design approach being fed by drug-loaded polymer granules and making filament strands obsolete. Oscillatory rheology is a key tool for understanding the behavior of a polymer melt in extrusion processes. In this study, small amplitude shear oscillatory (SAOS) rheology was applied to investigate formulations of model antihypertensive drug Metoprolol Succinate (MSN) in two carrier polymers for pharmaceutical three-dimensional printing (3DP). For a standardized printing process, the feeding polymers viscosity results were correlated to their printability and a better understanding of the 3DP extrudability of a pharmaceutical formulation was developed. It was found that the printing temperature is of fundamental importance, although it is limited by process parameters and the decomposition of the active pharmaceutical ingredients (API). Material characterization including differential scanning calorimetry (DSC) and thermogravimetric analyses (TGA) of the formulations were performed to evaluate component miscibility and ensure thermal durability. To assure the development of a printing process eligible for approval, all print runs were investigated for uniformity of mass and uniformity of dosage in accordance with the European Pharmacopoeia (Ph. Eur.). |
first_indexed | 2024-03-09T18:04:57Z |
format | Article |
id | doaj.art-f3c01b12b2b9410dbd1688d5812faa38 |
institution | Directory Open Access Journal |
issn | 1999-4923 |
language | English |
last_indexed | 2024-03-09T18:04:57Z |
publishDate | 2022-11-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceutics |
spelling | doaj.art-f3c01b12b2b9410dbd1688d5812faa382023-11-24T09:36:38ZengMDPI AGPharmaceutics1999-49232022-11-011411248810.3390/pharmaceutics14112488Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product CharacteristicsThomas Pflieger0Rakesh Venkatesh1Markus Dachtler2Karin Eggenreich3Stefan Laufer4Dominique Lunter5Digital Health Systems GmbH (DiHeSys), 73529 Schwaebisch Gmuend, GermanyDigital Health Systems GmbH (DiHeSys), 73529 Schwaebisch Gmuend, GermanyDigital Health Systems GmbH (DiHeSys), 73529 Schwaebisch Gmuend, GermanyGen-Plus GmbH & Co., KG, 81477 Munich, GermanyPharmaceutical Chemistry, Eberhard Karls University, 72074 Tuebingen, GermanyPharmaceutical Technology, Eberhard Karls University, 72074 Tuebingen, GermanyThe utilized 3D printhead employs an innovative hot-melt extrusion (HME) design approach being fed by drug-loaded polymer granules and making filament strands obsolete. Oscillatory rheology is a key tool for understanding the behavior of a polymer melt in extrusion processes. In this study, small amplitude shear oscillatory (SAOS) rheology was applied to investigate formulations of model antihypertensive drug Metoprolol Succinate (MSN) in two carrier polymers for pharmaceutical three-dimensional printing (3DP). For a standardized printing process, the feeding polymers viscosity results were correlated to their printability and a better understanding of the 3DP extrudability of a pharmaceutical formulation was developed. It was found that the printing temperature is of fundamental importance, although it is limited by process parameters and the decomposition of the active pharmaceutical ingredients (API). Material characterization including differential scanning calorimetry (DSC) and thermogravimetric analyses (TGA) of the formulations were performed to evaluate component miscibility and ensure thermal durability. To assure the development of a printing process eligible for approval, all print runs were investigated for uniformity of mass and uniformity of dosage in accordance with the European Pharmacopoeia (Ph. Eur.).https://www.mdpi.com/1999-4923/14/11/2488pharmaceutical three-dimensional printing (3DP)hot-melt extrusion (HME)printabilityoscillatory rheologynovel printhead design |
spellingShingle | Thomas Pflieger Rakesh Venkatesh Markus Dachtler Karin Eggenreich Stefan Laufer Dominique Lunter Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics Pharmaceutics pharmaceutical three-dimensional printing (3DP) hot-melt extrusion (HME) printability oscillatory rheology novel printhead design |
title | Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics |
title_full | Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics |
title_fullStr | Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics |
title_full_unstemmed | Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics |
title_short | Novel Approach to Pharmaceutical 3D-Printing Omitting the Need for Filament—Investigation of Materials, Process, and Product Characteristics |
title_sort | novel approach to pharmaceutical 3d printing omitting the need for filament investigation of materials process and product characteristics |
topic | pharmaceutical three-dimensional printing (3DP) hot-melt extrusion (HME) printability oscillatory rheology novel printhead design |
url | https://www.mdpi.com/1999-4923/14/11/2488 |
work_keys_str_mv | AT thomaspflieger novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics AT rakeshvenkatesh novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics AT markusdachtler novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics AT karineggenreich novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics AT stefanlaufer novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics AT dominiquelunter novelapproachtopharmaceutical3dprintingomittingtheneedforfilamentinvestigationofmaterialsprocessandproductcharacteristics |